CareLit · DOI-Nachweis · TumorDiagnostik & Therapie
An immunohistochemical investigation of the expression of somatostatin receptor subtypes – should therapeutic trials be performed to determine the efficacy of somatostatin analogs in treating advanced thyroid malignances?
DOI 10.1055/s-0035-1553893
Bibliografische Angaben
Nachweis in CareLit
Autor:innenN.N.
ZeitschriftTumorDiagnostik & Therapie
Ausgabe07/2015
Jahrgang / SeitenJg. 36 · S. 411-415
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Abstract Somatostatin and its analogs through the specific receptor are known to demonstrate antiproliferative, anti-angiogenic and pro-apoptotic actions. The presence of SSTR-1–5 has not been sufficiently explored in poorly differentiated and undifferentiated thyroid tumors. The aim was to investigate the SSTR subtypes expression in these aggressive thyroid tumors. The study also discusses the usefulness o…
Zitieren
Zitierempfehlung
N.N (2015) An immunohistochemical investigation of the expression of somatostatin receptor subtypes – should therapeutic trials be performed to determine the efficacy of somatostatin analogs in treating advanced thyroid malignances?. TumorDiagnostik & Therapie, 36 (07), 411-415. https://doi.org/10.1055/s-0035-1553893
Mit CareLit weiterarbeiten